Videos
David Hancock, healthcare executive advisor at InterSystems, discusses the need for interoperability when delivering healthcare to populations now and in the future.
        
        
          Efforts are underway to self-regulate drug price control with Malaysia's unique healthcare payment landscape, says Prince Court Medical Centre's Dr. Kuljit Singh.
        
        
          ConsejoSano offers a patient engagement platform that targets culturally diverse populations to make healthcare more accessible to those affected by social determinants, says the organization's COO Vikram Bakhru.
        
        
          CliniVantage co-founder and Managing Director Nilesh Jain provides insight into the ongoing trends in population health and chronic care management.
        
        
          Armin Scheuer, HIMSS VP of international business development, says Germany must focus on evolution over revolution in its efforts to advance healthcare digitally, but true value can only be realized with close stakeholder collaboration.
        
        
          Walter Pistor, director of digital health transformation at WebShield, describes how his company can help build networks for secure sharing of sensitive data.
        
        
          The patient is "the most underutilized resource in healthcare" and should be in the driver's seat of their own care, claim the Society for Participatory Medicine's Joseph Ternullo and Eric Bersh.
        
        
          HealthBeacon decided to go deep on one important medication adherence use case: self-administered injectables, says CEO Jim Joyce.
        
        
          Theo Fotis, principal lecturer at the University of Brighton's School of Health Sciences, says that because nurses represent the largest profession in healthcare, they are well-positioned to drive innovation with digital tools.
        
        
          Closed Loop Medicine CEO and co-founder Hakim Yadi  discusses why the development of digital health technologies should not stray "too far away" from the academic and clinic rigor applied to the pharma industry.